MX2009006656A - Homogeneous paste and gel formulations. - Google Patents

Homogeneous paste and gel formulations.

Info

Publication number
MX2009006656A
MX2009006656A MX2009006656A MX2009006656A MX2009006656A MX 2009006656 A MX2009006656 A MX 2009006656A MX 2009006656 A MX2009006656 A MX 2009006656A MX 2009006656 A MX2009006656 A MX 2009006656A MX 2009006656 A MX2009006656 A MX 2009006656A
Authority
MX
Mexico
Prior art keywords
optionally
provides
gel formulations
homogeneous paste
veterinary
Prior art date
Application number
MX2009006656A
Other languages
Spanish (es)
Inventor
Hassan Nached
Peter Hanson
Keith Freehauf
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/713,881 external-priority patent/US20080027011A1/en
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of MX2009006656A publication Critical patent/MX2009006656A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

This invention provides for a pharmaceutical or veterinary paste or gel formulation which may comprise an effective amount of a therapeutic agent; optionally an absorbent or a viscosity modifier; optionally a hydrophilic carrier, a colorant, stabilizer, surfactant, or preservative and optionally an antioxidant, solvent, flavoring, buffering system or thickener and methods of preparing these formulations. This invention also provides for, inter alia, oral homogeneous veterinary pastes or gels for the treating, controlling and preventing of endo- and ectoparasite infections in warm-blooded animals, such as birds, horses and household pets.
MX2009006656A 2007-03-05 2007-12-19 Homogeneous paste and gel formulations. MX2009006656A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/713,881 US20080027011A1 (en) 2005-12-20 2007-03-05 Homogeneous paste and gel formulations
PCT/US2007/088225 WO2008077130A2 (en) 2006-12-19 2007-12-19 Homogeneous paste and gel formulations

Publications (1)

Publication Number Publication Date
MX2009006656A true MX2009006656A (en) 2009-08-07

Family

ID=40984939

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006656A MX2009006656A (en) 2007-03-05 2007-12-19 Homogeneous paste and gel formulations.

Country Status (4)

Country Link
EP (1) EP2101736A4 (en)
CA (1) CA2673193C (en)
MX (1) MX2009006656A (en)
WO (1) WO2008077130A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018031935A1 (en) 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation Drug compositions
CA3087822C (en) * 2018-01-18 2022-08-02 Zoetis Broomhill Ip Limited Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow
US10857151B1 (en) * 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
WO2005063184A1 (en) * 2003-12-22 2005-07-14 Imrex, Inc. Methods and compositions for oral hygiene
EP2767163A1 (en) * 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals

Also Published As

Publication number Publication date
CA2673193A1 (en) 2008-06-26
CA2673193C (en) 2014-08-05
WO2008077130A2 (en) 2008-06-26
WO2008077130A3 (en) 2008-08-21
EP2101736A4 (en) 2012-09-19
EP2101736A2 (en) 2009-09-23

Similar Documents

Publication Publication Date Title
WO2007075827A3 (en) Homogeneous paste formulations
TNSN04258A1 (en) Anthelmintic oral homogeneous veterinary pastes
TW200621238A (en) Pharmaceutical formulation
BR0108449A (en) Enhanced Folder Formulations
EP3640246A4 (en) N2,n4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer
CR8480A (en) VETERINARY FORMULATIONS CONTAINING NON-ANIMAL PRODUCT
EP3895717A4 (en) Pharmaceutical composition for preventing or treating cancer, comprising weissella cibaria wikim28 as active ingredient
CY1112106T1 (en) PREVENTIVE HORMONE PREPARATIONS AND THEIR USE
MX356926B (en) Topical localized isoxazoline formulation.
WO2010059719A3 (en) Dimeric 1-arylpyrazole derivatives
WO2009129352A8 (en) Device and method for accessing and treating ducts of mammary glands
MX2010009743A (en) Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members.
BR112015028692A8 (en) preventive or therapeutic agent for ruminant animal mastitis
MX2009006656A (en) Homogeneous paste and gel formulations.
MX2014006601A (en) Long-acting injectable moxidectin formulations and novel moxidectin crystal forms.
EP2422816A4 (en) A drug composition for treating tumor with polymeric micelle encapsulating antineoplastic
IL284930A (en) Pyrrolopyrimidine derivative, and pharmaceutical composition for preventing or treating protein kinase-related disease comprising same as active ingredient
WO2015081319A3 (en) Activity enhancing curcumin compositions and methods of use
NZ622869A (en) Stable veterinary anthelmintic formulations
MX2020007760A (en) Compositions and methods of enhancing 5-hydroxytryptophan bioavailability.
WO2014144584A3 (en) Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
PE20151726A1 (en) STABLE VETERINARY FORMULATIONS OF COMBINATION OF MACROCYCLIC LACTONES AND IMIDAZOTHIAZOLES
CY1109541T1 (en) PHARMACEUTICAL FORMULATION FOR OSTEOHTHRITIS THERAPY CONTAINING CLODRONIC ACID AND HALURONIC ACID
EP3763735A4 (en) Method for preparing biomaterial having selectively functionalized tyrosine, biomaterial having selectively functionalized tyrosine, and pharmaceutical composition containing same as active ingredient
WO2009045575A3 (en) Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins

Legal Events

Date Code Title Description
FA Abandonment or withdrawal